These observations may be related to earlier studies showing oncogenic effects of IRF2 suppression [29], although overexpression of IRF2 has also been reported to cause oncogenic transformation in pancreatic cancers and leukemias [30–32]. This evidence concerns the gene IRF2 and leukemia.